Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark; Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Eur J Obstet Gynecol Reprod Biol. 2024 Nov;302:116-124. doi: 10.1016/j.ejogrb.2024.09.001. Epub 2024 Sep 6.
Existing guidelines for screening and treatment of asymptomatic bacteriuria (ASB) in pregnancy are based on studies completed more than 30 years ago. This evidence is characterized by a lack of consensus on the association between ASB and adverse pregnancy- and birth outcomes.
This systematic review aimed to investigate the association between untreated/treated ASB (≥10 colony-forming units (cfu) of the same bacteria per ml urine in two consecutive voided cultures without any symptoms) and pregnancy outcomes (pyelonephritis, chorioamnionitis, prelabour rupture of membranes (PROM)), and birth outcomes (preterm birth (PTB), low birth weight (LBW) and small for gestational age (SGA)). The impact of the most serious pathogens E. coli and Group B streptococci (GBS) on these outcomes was also examined.
A systematic literature search was prepared according to the guideline Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA). The search was conducted in the databases Medline, Embase, and Cochrane Library, with a systematic strategy based on the PICO acronym (Population, Intervention, Comparison, Outcome). Covidence was used as a screening- and data extraction tool. Randomized trials and observational studies published between, January 01, 2005-February 10, 2023, were identified. The Cochrane Collaboration risk of bias tool 2 and the Newcastle-Ottawa Quality Assessment Scale were applied to assess the quality of the included studies. A protocol was published prior to this review, at the international prospective register of systematic reviews (PROSPERO).
The database search yielded 3029 records. Fourteen studies were included. Untreated pregnant women with ASB had significantly increased odds of pyelonephritis. Most of the studies showed no significant association between treated ASB and pyelonephritis. In treated ASB, an increased risk of both chorioamnionitis and PROM was found. Divergent results were found in the association between ASB and PTB, as well as in the association between untreated ASB and LBW. Most of the studies showed no significant association between treated ASB and LBW. One study found no significant association between untreated/treated ASB and SGA. No studies were identified that addressed the association between ASB with E. coli/GBS and the outcomes examined.
There is a need for more recent high-quality studies to investigate the association between untreated/treated ASB and pregnancy- and birth outcomes, and to assess the impact of E. coli/GBS on these outcomes.
现有的无症状菌尿(ASB)筛查和治疗指南是基于 30 多年前完成的研究制定的。这些证据的特点是缺乏共识,无法确定 ASB 与不良妊娠和分娩结局之间的关联。
本系统评价旨在研究未经治疗/治疗的 ASB(连续两次排空尿液培养中同一细菌每毫升尿液的菌落形成单位(cfu)≥10,无任何症状)与妊娠结局(肾盂肾炎、绒毛膜羊膜炎、胎膜早破(PROM))和分娩结局(早产(PTB)、低出生体重(LBW)和小于胎龄儿(SGA))之间的关系。还研究了最严重的病原体大肠埃希菌和 B 组链球菌(GBS)对这些结局的影响。
根据系统评价和荟萃分析的首选报告项目(PRISMA)指南,准备了系统文献检索。在 Medline、Embase 和 Cochrane Library 数据库中进行了搜索,使用基于 PICO 缩写(人群、干预、比较、结局)的系统策略。Covidence 被用作筛选和数据提取工具。确定了 2005 年 1 月 1 日至 2023 年 2 月 10 日期间发表的随机试验和观察性研究。应用 Cochrane 协作风险偏倚工具 2 和纽卡斯尔-渥太华质量评估量表来评估纳入研究的质量。在本次评价之前,在国际前瞻性系统评价注册平台(PROSPERO)上发布了一份方案。
数据库搜索产生了 3029 条记录。纳入了 14 项研究。未经治疗的 ASB 孕妇发生肾盂肾炎的几率显著增加。大多数研究表明,治疗后的 ASB 与肾盂肾炎之间没有显著关联。在治疗后的 ASB 中,发现绒毛膜羊膜炎和 PROM 的风险均增加。ASB 与 PTB 以及未经治疗的 ASB 与 LBW 之间的关联存在不同的结果。大多数研究表明,治疗后的 ASB 与 LBW 之间没有显著关联。一项研究发现,未经治疗/治疗的 ASB 与 SGA 之间没有显著关联。没有研究确定 ASB 与大肠埃希菌/GBS 之间的关系以及所检查的结局之间的关系。
需要更多最近的高质量研究来调查未经治疗/治疗的 ASB 与妊娠和分娩结局之间的关系,并评估大肠埃希菌/GBS 对这些结局的影响。